November 25, 2020NORDIC SHIPHOLDING A/S Company Announcement: 10/2020 Published via NASDAQ OMX on November 25, 2020 Q3 Result 2020 Summary The comparison figures for period ended 30 September 2019 are stated in parenthesis.The very high Time Charter Equivalent (“TCE”) rates arising from the short-term surge in demand for tonnage caused by the COVID-19 pandemic and the oil price war which started in Q1 2020 positively impacted the Group’s earnings in 9M 2020. Despite the downward correction in daily TCE rate from May 2020, the average daily TCE rates earned in Q3 2020 and 9M 2020 by the 5 vessels were approximately 11% and 53% higher than the average TCE rates earned in Q3 2019 and 9M 2019, respectively.The TCE revenue in Q3 2020 falls short of expectation due to lower than expected daily TCE rates, exacerbated by lower contribution from Nordic Hanne as she was off-hired since 11 September 2020 due to a contact damage during a Ship-to-Ship operation. She resumed trading on 28 October 2020.For the 9 months ended 30 September 2020, the Group incurred a loss after tax of USD 3.9 million (including a one-off impairment loss of USD 10.7 million on the vessels), compared to a loss after tax of USD 4.7 million in the same period last year. Excluding the impairment loss of USD 10.7 million (USD 0.2 million), the Group generated a profit after tax of USD 6.8 million for the 9 months under review (loss after tax of USD 4.5 million). The improved TCE revenue from the vessels contributed to the improved results in 9M 2020.Despite the sale of Nordic Ruth in July 2019, TCE revenue rose 57.3% to USD 24.0 million (USD 15.2 million) in 9M 2020 primarily from higher TCE revenue generated by the vessels in the pools compared to the same period last year. Further, the TCE revenue in 9M 2019 were impacted negatively by the dry-dock of 3 vessels (Nordic Anne, Nordic Agnetha and Nordic Amy) in Q3 2019.Expenses relating to the operation of vessels in 9M 2020 decreased to USD 8.6 million (USD 10.8 million) mainly due to the sale of Nordic Ruth in July 2019.EBITDA increased significantly to USD 14.2 million (USD 3.3 million) as a result of improved TCE revenue in 9M 2020. Other external costs remained relatively unchanged at USD 1.0 million (USD 1.0 million).In line with management’s strategy to secure longer term financing in the renegotiation of the Group’s loan facilities, two co-brokers were appointed in May 2020 to officially test the buying interest for one vessel, Nordic Hanne, a handysize tanker. Hence, the Group recognised impairment losses totaling USD 4.2 million in 9M 2020 following the reclassification of Nordic Hanne as an asset held-for-sale in Q2 2020. It is noted that the estimation of Nordic Hanne’s expected sale value is highly uncertain. The Group also recognised impairment losses of USD 6.5 million on the other four vessels in 9M 2020 primarily due to reduced earnings expectations. The Group realised a loss of USD 0.2 million on asset-held-for-sale in 9M 2019 related to the sale of Nordic Ruth in July 2019.After accounting for depreciation, impairment losses, interest expenses and other finance expenses, the loss after tax was USD 3.9 million in 9M 2020 (loss of USD 4.7 million).Between 31 December 2019 and 30 September 2020, equity decreased from USD 7.9 million to USD 4.0 million as a result of the cumulative loss during the period. Consequently, the equity ratio declined from 8.1% to 5.1%.As part of the loan restructuring concluded with the lending banks in Q4 2018, the financial covenants under the original loans such as (i) minimum value (fair market value of vessels as a percentage of outstanding loan) and (ii) minimum equity ratio are waived whilst the minimum liquidity level is reduced. The relief from these financial covenants are provided till and including 30 September 2020. In addition, the quarterly loan instalments due from December 2018 to September 2020 are deferred to December 2020 where all of the Group’s debts to the lending banks mature. The Company, together with its majority shareholder, are in active discussions with the lending banks on securing longer term financing for the Group. Negotiations are ongoing and are expected to be completed during December 2020 when an announcement will be published. It is management’s expectation that the lenders will finance the Company in a period longer than 31 December 2020.The Group is also subject to a quarterly cash sweep mechanism under which the Group after payment of instalments and interest under the loan agreement, must apply any cash and cash equivalents of the Group in excess of USD 6.0 million towards prepayment of the loan. During 9M 2020, this cash sweep mechanism was activated on 31 March 2020, 30 June 2020 and 30 September 2020, and a total of USD 13.3 million excess cash was used to pay down the loan (USD NIL cash sweep for 9M 2019).During the financial period under review, cash flow generated from operations was USD 14.1 million (USD 2.0 million) contributed by earnings from the pools. As at 30 September 2020, cash and cash equivalents stood at USD 6.2 million (USD 6.4 million, including balances held in dry-docking reserve bank accounts).The outlook for 2020 remains unchanged as indicated in the Company Announcement 09/2020 on 20 November 2020.For the rest of 2020, the five vessels will continue to be commercially deployed on a pool basis (including the vessel currently earmarked for sale). Barring unforeseen circumstances, the TCE revenue for 2020 is forecasted to be in the region of USD 27.0 million – USD 29.0 million.After accounting for operating expenditure budgeted by the respective technical managers, the Group’s expected EBITDA (earnings before interest, tax, depreciation and amortisation) for 2020 is in the range of USD 13.0 million – USD 15.0 million. The result before tax is expected to be a loss between USD 5.0 million – USD 7.0 million including impairment loss. For further information please contact: Knud Pontoppidan, Chairman of the board, Nordic Shipholding A/S: +45 39 29 10 00Attachment * NSH Q3 2020 Financial announcement
Demand for food & beverage products and growing emphasis on revolutionary printing technology will proliferate in the global packaging printing sectorDallas, Texas, Nov. 25, 2020 (GLOBE NEWSWIRE) -- The “Packaging Printing Market by Printing Technology (Flexography, Offset, Gravure, Screen Printing, and Digital printing), Printing Ink (Solvent-Based Ink, Aqueous Ink, UV Curable Ink, Latex Ink, and Others), Applications (Household & Cosmetic Products, Food & Beverages, Pharmaceutical, and Others), Packaging Type (Labels, Glass, Plastic, Metal, Paper & Paperboard, Cartons, and Others), and by Region, Global Forecast, 2018 to 2028” study provides an elaborative view of historic, present and forecasted market estimates.Request a pdf sample at https://www.adroitmarketresearch.com/contacts/request-sample/1470The global packaging printing market size is projected to grow from USD 320.6 billion in 2019 to USD 440.6 billion 2028. The packaging printing provides the package with quality printing, which in turn meets industry demands. It uses numerous printing methods, including flexography, digital printing, engraving, screen printing, and offset printing. It is used for many processes of packaging, including rigid plastic paper & paperboard, glass, and metal. Furthermore, the packaging technology industries include food & beverages, pharmaceutical and other industries. Adroit Market Research study on the global market for packaging printing offers a holistic view of the industry from 2020 to 2028 as forecast period, including factors such as market drivers, limitations, opportunities, threats and regulatory overview. The market has been analyzed from 2018 to 2028, with a base year estimate of 2019 and a projection from 2020 to 2028. The report covers the current status and potential characteristics of the market at both the global and the country level. Moreover, the report also assesses market competition with Porter's analysis of five strengths and places leading players on the basis of their product range, regional presence, strategic initiatives and overall sales. Prominent players in the global composite resin market have been analyzed in depth.Browse the full report with Table of Content and List of Figures at https://www.adroitmarketresearch.com/industry-reports/packaging-printing-marketThe demand for packaged goods and items coupled with shifting emphasis to online shopping is growing paper dependence. Moreover, the growing tendency towards flexible packaging along with steady growth across print media, including newspapers and newspapers, is stimulating demand for paper. In addition, ongoing innovation activities to boost the properties of printing materials in the coming years will complement the size of the industry. In addition to this, the report sheds light on various aspects of the global packaging printing industry by analyzing the sector using value chain analysis. The study covers many qualitative aspects of market factors for the packaging printing industry, market constraints and key developments in the sector. Furthermore, the study offers a comprehensive overview of market rivalry with global company profiles of global as well as local vendors.Are you looking for a DISCOUNT? If yes, then get in touch with us at https://www.adroitmarketresearch.com/contacts/discount/1470On the basis of application, the demand for packaging printing is classified into household & cosmetic products, food & beverages, pharmaceutical and others. The food & beverage segment is projected to rise over the forecast period 2020-2028 at a CAGR of over 5 per cent. Growth in this segment is primarily contributing to growing packaged food consumption along with increasing importance of the presence of packaging would increase the demand for the product in the coming years.Europe is expected to keep pace with strong growth over the projected period. The ongoing launch of enhanced printing technologies for printing along with ongoing development across the packaging industry is boosting the region's industry size. The major players of the global Packaging Printing market comprise of Mondi, Sonoco Products Company, Graphics Packaging Holding Company, Quad/Graphics, Amcor Limited, Constantia Flexibles, and WS Packaging Group, including others.Direct purchase the report at https://www.adroitmarketresearch.com/researchreport/purchase/1470Major Points from Table of Contents: Chapter 1 Executive Summary Chapter 2 Research Methodology Chapter 3 Executive Summary Chapter 4 Market Outlook Chapter 5 Packaging Printing Market by Printing Technology Chapter 6 Packaging Printing Market by Printing Ink Chapter 7 Packaging Printing Market by Application Chapter 8 Packaging Printing Market by Packaging Type Chapter 9 Packaging Printing Market by Region Chapter 10 Competitive Landscape Chapter 11 Company Profiles Chapter 12 AppendixAccess research repository of Upcoming Reports @ https://adroitmarketresearch.com/upcoming.html About Us: Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.Contact Us: Ryan Johnson Account Manager - Global 3131 McKinney Ave Ste 600 Dallas, TX 75204 Email ID: firstname.lastname@example.org Phone No.: +1 972-362 -8199 Connect with us: Facebook | Twitter | LinkedIn
Japan used a visit by the Chinese foreign minister on Wednesday to protest Beijing's increased activity and what it calls infiltration around disputed East China Sea islands. “The situation is extremely serious,” Chief Cabinet Secretary Katsunobu Kato told reporters after meeting with Chinese Foreign Minister Wang Yi, who arrived in Tokyo on Tuesday for a two-day visit. Relations between the two countries have been strained over territorial disputes and wartime history, even though ties have improved in recent years while China’s trade dispute with the U.S. has escalated.
(Bloomberg) -- A leading Chinese vaccine developer has applied for authorization to bring its Covid-19 shot to the market, seeking to get a jump on Western rivals as the race for a working inoculation against the virus enters the final stretch.China National Biotec Group Co. has submitted an application to Chinese regulators, reported state media Xinhua Finance on Wednesday, citing parent company Sinopharm’s vice general manager Shi Shengyi. The application likely includes interim data from the company’s Phase III human testing conducted in the Middle East and South America.Stocks related to Sinopharm Group, including its Hong Kong unit, surged on Wednesday after the news.A CNBG spokeswoman said she had no further information when contacted by Bloomberg. Calls to Sinopharm Group went unanswered.With the application, CNBG will likely become the first developer outside of Russia to see its shots made available for general public use, underscoring China’s determination to be a major player in supplying inoculations to countries around the world. Western drugmakers like Pfizer Inc. and AstraZeneca Plc are only at the stage of seeking authorization for emergency use of their shots, a status China granted to its developers months ago.But unlike western frontrunners, CNBG has yet to release any public data on the efficacy of its shots in Phase III trials, making it difficult to compare its vaccines to others, or estimate how quickly it is likely to receive approval.The regulator will now review data from CNBG’s Phase I and II trials, plus interim data from its Phase III trials, which Chairman Yang Xiaoming said last week the company has just started un-blinding. China’s drug regulator, the National Medical Products Administration, did not immediately respond to requests for comment.The vaccine race has taken on vital importance as countries look to more definitively re-open their economies and stem a pandemic that has sickened more than 59 million. Inoculations are seen as the best hope as a fresh wave of infections is forcing nations to reintroduce lockdowns and other restrictions.Traditional MethodA state-owned drugmaker that has a dominant share of China’s vaccine market, CNBG in April was among the world’s first to push experimental shots to the crucial final stage of human testing. The company’s research institutes developed two shots using an inactivated version of the virus to stimulate immune response, an approach widely adopted by many of the existing vaccines used around the world.Such vaccines have the advantage of easier storage and distribution as they don’t need to be frozen -- unlike the experimental mRNA vaccines being developed by Pfizer and Moderna Inc. CNBG’s shots can be stored at normal refrigerator temperatures, making access for rural areas and developing countries more likely.CNBG has vaccine supply agreements with several developing countries including Malaysia, Brazil, Pakistan and the United Arab Emirates, according to public reports compiled by Bloomberg. Leading Western developers like AstraZeneca and Pfizer have inked agreements with far more countries.Despite the fact that the vaccines haven’t yet received regulatory approval for widespread use, doses have already been given to hundreds of thousands of people in China under an emergency-use program. That has raised concern among scientists of potential risks in using shots whose safety has yet to be thoroughly studied.CNBG has said that its phase III trials -- involving more than 50,000 people in countries from Argentina to Egypt -- have been progressing smoothly, and it has not received any reports of serious adverse events.Safety has become a major concern as drugmakers compress the vaccine development process from years to a matter of months. AstraZeneca and Johnson & Johnson paused their trials after a participant developed an unexplained illness. Another Chinese frontrunner, Sinovac Biotech Ltd., also saw its trial briefly halted in Brazil after a participant died. All three trials resumed after investigators found no evidence that the events were caused by the vaccines.Pfizer said this month that the shot it co-developed with BioNTech has a protection rate of more than 90%. This high level of efficacy was also seen in Moderna’s shots, which use a similar mRNA technology. AstraZeneca’s vaccine, a viral vector developed with the University of Oxford, stopped an average of 70% of participants from falling ill, an early analysis showed.(Updates throughout)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
The Digital Publishing Market will grow by USD 64.83 bn during 2020-2024
Bill.com Announces Pricing of Upsized Offering of $1.0 Billion of 0% Convertible Senior Notes due 2025
Hong Kong leader Carrie Lam said Wednesday that the city's new national security law has been “remarkably effective in restoring stability” after months of political unrest, and that bringing normalcy back to the political system is an urgent priority. Lam made the comments in her annual policy address, more than a month after it was postponed so that she could seek Beijing’s support for various economic measures aimed at reviving the semi-autonomous Chinese territory's economy. Beijing imposed the national security law on Hong Kong in June, aiming to crack down on dissent following months of anti-government protests in the city that at times descended into violence.
The electric vehicle pioneer's business has plenty of long-term promise, but it's the short run that most people are looking at right now.
India has registered 44,376 new confirmed coronavirus cases in the past 24 hours. The latest increase has taken the total number of cases to 9.22 million, the Health Ministry said Wednesday. India’s confirmed daily toll has remained below 50,000 for a few weeks, after peaking in September.
Corporate Meeting Cards market is expected to grow by USD 46 billion as we reach 2024. This is due to the impact of the COVID-19 pandemic in 2020
(Bloomberg) -- Oil kept rising after closing at a eight-month high on increasing optimism that recent Covid-19 vaccine breakthroughs will lead to a swift recovery in global energy demand next year.Futures in New York climbed around 1% to trade above $45 a barrel as a broader financial markets rally continued. Global benchmark Brent crude could reach $60 a barrel by the summer of 2021 as the easing of travel restrictions boosts demand for fossil fuels, according to Bank of America Corp.In another positive sign for consumption, Premier Li Keqiang said China, the world’s biggest oil importer, will likely return to a more “proper” range of economic development in 2021. China and Japan also agreed to restart some two-way travel by the end of November. Crude surged 4.3% on Tuesday after the triggering of a formal transition process to U.S. President-elect Joe Biden. Oil’s value has increased by more than a quarter this month amid positive results for three Covid-19 vaccines. It’s reclaimed heights not seen since the pandemic devastated global demand in March even as a resurgent virus prompted more lockdown measures. Expectations that OPEC and its allies will delay an increase in production planned for January have also aided the rally.The investor mood has been lifted by the developments around vaccines and the likely extension of the OPEC+ output cuts, said Daniel Hynes, a senior commodity strategist at Australia & New Zealand Banking Group Ltd. “The market is fairly well-priced and should continue gains in the coming days.”Goldman Sachs Group Inc. said in a note that it expects OPEC+ to delay its planned 2 million barrel a day output ramp-up by three months. It forecast Brent would average $47 a barrel next quarter if this happens.See also: Oil Curve Flips Most Bullish in Months After Vaccine RallyThe optimism is reshaping oil’s forward curves. Brent’s prompt timespread and the so-called WTI red spread -- which measures futures for December of next year to December 2022 -- have both flipped to backwardation this week, a bullish signal that suggests the market may be moving into deficit.The American Petroleum Institute, meanwhile, reported crude inventories swelled by 3.8 million barrels, according to people familiar with the data. That would be the third straight week of rising stockpiles if confirmed by government figures due later on Wednesday. Inventories probably rose by 225,000 barrels last week, according to the median estimate in a Bloomberg survey before the official Energy Information Administration data.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
The MILLA POD The MILLA Group has selected the award-winning Leddar™ Pixell as the front-end LiDAR for their MILLA POD autonomous shuttle. The MILLA POD The MILLA Group has selected the award-winning Leddar™ Pixell as the front-end LiDAR for their MILLA POD autonomous shuttle.QUEBEC CITY, Nov. 25, 2020 (GLOBE NEWSWIRE) -- LeddarTech®, a global leader in Level 1-5 ADAS and AD sensing technology, is proud to have been selected by the MILLA Group as the supplier for their cocoon LiDAR sensor. The MILLA Group has selected the award-winning Leddar™ Pixell as the front-end LiDAR for their MILLA POD autonomous shuttle. The Leddar Pixell is the most robust solid-state LiDAR on the market. This sensor provides a 180-degree horizontal field of view (FoV) and can offer 360-degree coverage of a vehicle when four modules are used. The Leddar Pixell offers best-in-class shock and vibration resistance meeting ISO 16750-3 requirements and complies with the SAE J1455 standard for heavy dust intrusion, positioning the Leddar Pixell for use in the industrial vehicle markets requiring robustness and durability. Also, the Leddar Pixell is IP67 certified and provides an MTBF of more than 148,000 hours, which is equivalent to ten times that of scanning solutions. The Leddar Pixell is ideal for shuttles, robotaxis, ADVs, and other off-road vehicles used in construction, agriculture, and mining applications.“MILLA has engaged with LeddarTech on the robust Leddar Pixell for our MILLA POD. The POD is an innovative autonomous shuttle that has been deployed throughout Europe and North America,” stated Éric Gendarme, Managing director of the MILLA Group. “The radical changes we implemented in the POD related to the design lend themselves well to the Leddar Pixell; this LiDAR enables us to have a 180-degree field of view, which increases safety and overall reliability of our autonomous shuttle.” Mr. Gendarme continued: “The MILLA POD, equipped with Leddar Pixell along with the other autonomous technology components that make up our operating systems, was submitted to the RATP Group, a State-owned public transport operator operating in 13 countries and on four continents, tasked with evaluating and qualifying autonomous public transportation vehicles. The RATP reported that the operating systems of the MILLA POD, which included the Leddar Pixell, meet the stringent qualification requirements,” Mr. Gendarme concluded.“We are honored to be a chosen supplier to MILLA Group for our sensing technology,” stated Frantz Saintellemy, President and COO of LeddarTech. “The MILLA Group represents a forward-thinking organization that tackles autonomous shuttle technology with a new and innovative approach; we are proud that our Leddar Pixell contributed to MILLA’s technical certification with the RATP Group,” Mr. Saintellemy concluded.About MILLA GroupMILLA Group is a leading independent French company of engineers specialized in the design, development, fabrication, and experimentation of new mobility products and services. MILLA’s new mobility concept is to provide a sustainable, modular, scalable, and adaptable transporting service accessible to everyone. Since 2019, MILLA’s shuttles are rolling daily on open roads at the speed of 30 km/h in autonomous mode, a unique service on Earth. Today MILLA is the only mobility provider proposing on-demand and multi-modal transportation solutions (people and goods) for rural and peri-urban zones. The technologies implemented by MILLA Group have significant impacts also on the automotive industry. Major world-leading companies are using MILLA’s services, such as robotization and automation of vehicles and their experimentation on open roads.Contact Éric Gendarme at email@example.comAbout LeddarTechLeddarTech is a leader in environmental sensing platforms for autonomous vehicles and advanced driver assistance systems. Founded in 2007, LeddarTech has evolved to become a comprehensive end-to-end environmental sensing company by enabling customers to solve critical sensing and perception challenges across the entire value chain of the automotive and mobility market segments. With its LeddarVision™ sensor-fusion and perception platform and its cost-effective, scalable, and versatile LiDAR development solution for automotive-grade solid-state LiDARs based on the LeddarEngine™, LeddarTech enables Tier 1-2 automotive system integrators to develop full-stack sensing solutions for autonomy level 1 to 5. These solutions are actively deployed in autonomous shuttle, truck, bus, delivery vehicle, smart city/factory, and robotaxi applications. The company is responsible for several innovations in cutting-edge automotive and mobility remote-sensing applications, with over 95 patented technologies (granted or pending) enhancing ADAS and autonomous driving capabilities.Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook, and YouTube.Contact: Daniel Aitken, Vice-President, Global Marketing, Communications and Product Management, LeddarTech Inc. Tel.: + 1-418-653-9000 ext. 232 firstname.lastname@example.orgLeddar, LeddarTech, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, VAYADrive, VayaVision, and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names, and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.Photos accompanying this announcement are available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c4ce9937-f7fa-4d83-8c7d-a7106c467340 https://www.globenewswire.com/NewsRoom/AttachmentNg/64706fa3-751d-4a2d-b9eb-336c4a7f8d6f
(Bloomberg) -- Global equities were on course for the best month on record as a rally picked up steam on Wednesday and cash continued to flow into cyclical sectors. The dollar held a decline.Asia-Pacific shares rose, with energy and financial stocks leading the advance, though gains fizzled in China and South Korea. S&P 500 futures pushed higher after the benchmark index closed at an all-time high and the Dow Jones Industrial Average topped 30,000 for the first time. Treasuries steadied after the yield curve steepened Wednesday. Oil held above $45 a barrel in New York. Copper reached the highest since 2014.Positive vaccine news has fueled optimism that the global economic recovery can weather a surge in coronavirus infections, while investors embraced clarity on the formal start of President-elect Joe Biden’s transition and his Treasury Department’s likely policy preferences under Janet Yellen. The MSCI gauge of global shares is up 13% in November, set for its best month since it began in 1988. That’s despite stepped up restrictions to curb the pathogen, including in the U.S. ahead of the Thanksgiving holiday.“The markets have good reasons to extend this risk rally because now we have clarity on the peaceful transition of leadership in the U.S. and positive vaccine developments,” said Fan Cheuk Wan, head of investment strategy for Asia at HSBC Private Bank. “Investors are now focused on the recovery outlook,” she said on Bloomberg Television. The rally “will likely have further legs to go and the earnings recovery in 2021 will be a key fundamental support.”Next up Wednesday comes a slew of U.S. economic indicators, from jobless claims to readings on consumer confidence and personal income.Elsewhere, Bitcoin topped $19,000 as it closed in on a record. In New Zealand, bond yields climbed to the highest since July as the case for negative interest rates wanes.Here are some key events coming up:Minutes of the most recent Federal Open Market Committee meeting are due Wednesday.U.S. jobless claims, GDP and personal spending data come Wednesday.U.K. Chancellor of the Exchequer will lay out spending plan on Wednesday.Thursday sees a policy decision and briefing from the Bank of Korea.U.S. celebrates the Thanksgiving holiday on Thursday.The week ends with Black Friday, the traditional start of the U.S. holiday shopping season.These are the main moves in markets:StocksS&P 500 Index futures added 0.3% as of 1:55 p.m. in Tokyo. The gauge rose 1.6% on Tuesday.Japan’s Topix index advanced 0.6%.Hang Seng Index rose 0.9%.Shanghai Composite Index dipped 0.2%.South Korea’s Kospi index fell 0.2%.Euro Stoxx 50 futures advanced 0.6%.CurrenciesThe Bloomberg Dollar Spot Index dipped 0.1%.The euro bought $1.1905, up 0.1%.The yen was at 104.47 per dollar, little changed.The offshore yuan traded at 6.5730 per dollar.BondsThe yield on 10-year Treasuries held at 0.88%.Australia’s 10-year yield climbed about four basis points to 0.93%.CommoditiesWest Texas Intermediate crude rose 1.1% to $45.38 a barrel.Gold was at $1,804.90 an ounce, down 0.2%.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
\--Company provides summary of activities in California VANCOUVER, British Columbia, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTC: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a premier California based multi-faceted life sciences company focused on the commercialization of Cannabis products and formulations, is pleased to announce the commencement of trading on the Börse Frankfurt exchange (FRA) under the ticker symbol “4VV.” Additionally, the international registry ISIN number is CA48222R1010 and the German WKN registry number is A2QHTZ. For those new to the Juva story a summary of past and future activities is outlined below and available on the Company website at www.juvalife.com.Juva Life California Subsidiary Juva Life Inc. USA, a California corporation and wholly owned subsidiary of Juva Life Inc. (as of May 30, 2019) was originally incorporated in 2018 and represents the culmination of decades of concentrated effort in the cannabis sector. Juva Stockton Inc. a wholly owned subsidiary of Juva Life Inc holds a Conditional Use Permit (“CUP”) from the city of Stockton, California which, subject to certain conditions, permits the Company to cultivate, manufacture, distribute and deliver cannabis for the medical and recreational markets within the State. Juva Stockton successfully launched its delivery service from this location in October 2020. Additionally, in October 2020, after a 2.5-year process, Precision Apothecary Inc, a wholly owned subsidiary of Juva Life Inc, now holds a CUP allowing for a Microbusiness operation in the City of Hayward, California. This permit will allow Juva to cultivate, manufacture, formulate, research, distribute and operate a retail cannabis storefront and delivery business in that municipality. Concurrently, the Company’s Redwood City delivery location has been fully operational since February 2020 and has experienced double-digit growth month over month since commencement of operations.Capital Raise On May 31, 2020, Juva Life closed a private placement financing with cumulative gross proceeds in excess of $18,000,000. As of June 30, 2020, the Company had working capital of $8,270,000 (excluding warrant liability). Use of funds to-date includes costs for facility construction and equipment, licensing and permitting, marketing, branding, staff recruitment and implementation of sales personnel, pipeline project acquisitions and general administration.Corporate Divisions The Company is made up of six divisions: Cultivation, Research, Manufacturing, Distribution, Retail and Delivery. Each division services specific vertical markets within a fully integrated framework under the guiding premise of commercially engaging the many ways cannabis can fundamentally improve individual quality of life.Strategic Plan Juva Life’s strategic plan is to be a fully autonomous, vertically-integrated cannabis business with two primary missions: (1) to achieve the lowest cost of production by owning licenses for retail sales, manufacturing, distribution and cultivation of cannabis and to employ each license to propel our supply chain with select brick and mortar storefronts and multiple delivery businesses throughout the State of California; and (2) to develop "precision cannabis" products that deliver the right formulation to the right individual at the right time. Juva plans to develop intellectual property and secure patent protection on each of its custom medical formulations and will focus its research registries in areas of inflammation, oncology, neurology, pain management and opiate reduction.Management & Advisors Led by Founder & CEO Doug Chloupek, the Juva Life team brings over 20 years management experience in the cannabis sector. Their knowledge and experience provide operational oversight in navigating the regulatory framework of the California cannabis market. Additionally, the Company has attracted an advisory board of highly respected and influential doctors, clinicians, and researchers from fields of medicine that range from pain management to oncology. Find out more about our team at https://juvalife.com/about/.Production, Operations and Management Facilities Juva Life currently has five leased properties and one option to lease space in the cities of Stockton, Hayward and Redwood City, California, and is in the process of building out its facilities and obtaining the necessary State and local authorizations to undertake its current and proposed operations.Stockton, California San Juan and Navy Drive Facilities Currently developing two locally permitted cannabis production facilities totaling approximately 41,448 square feet, including: (1) an approximate 30,000 square foot production facility located on San Juan Drive in Stockton, California; and (2) an approximate 11,448 square foot facility located on Navy Drive in Stockton, California. These facilities will support cultivation, manufacturing, retail sales (non-storefront delivery only) and wholesale distribution supporting direct-to-consumer delivery operations in the north San Joaquin Valley as well as operate as the Corporation's Central Valley distribution hub.The San Juan facility is fully licensed by the city and state for delivery services and began Non-storefront retail (delivery) in October 2020. The facility is licensed by the city for cultivation, manufacturing and distribution and subject to final state approval, is poised to immediately commence cultivation operations.Hayward, California Clawiter Road and Enterprise Avenue Buildings The Hayward Facilities consist of two adjacent buildings with an existing Class 5 clean room as part of the 18,000 square foot building and 11,000 square feet of greenhouses for cultivation. The Hayward operation includes cultivation of high-quality greenhouse material for extraction, a flagship retail store, a delivery hub for the entire East San Francisco Bay area, CO2 extraction, formulation, isolation and contract product development. The Hayward campus totals approximately 35,000 square feet and is also planned to offer "white labeling" services to provide new or existing brands to introduce products to the California marketplace.Juva Life received approval of their CUP in October 2020. Management expects construction of the R&D lab to be completed, and the lab facilities to be licensed and operational by the end of Q1 2021. Juva further expects construction on the cultivation, retail, manufacturing area and distribution facilities at the Hayward buildings to be completed, licensed and operational by the end of Q3 2021.Redwood City, California Convention Way Facility, Redwood City Offices Non-storefront retail (delivery) cannabis facility. This delivery operation services the Bay Area Peninsula from San Francisco to San Jose. Juva believes its dispatch service area encompasses approximately 1.67 million potential customers. Juva obtained approval of its local Redwood City Cannabis Business Permit and Conditional Use Permit in May, 2019, and the State license was issued in September 2019. The Corporation formally began delivery operations in January of 2020 and has seen double digit growth quarter on quarter. Additionally, Juva occupies approximately 2,000 square feet of office space used for executive offices in Redwood City, CA.Mr. Doug Chloupek, CEO and Founder of Juva Life Inc. notes, “Coming on the heels of our recent launch onto the North American markets, we are delighted to announce our entry into the European marketplace via our Frankfurt market listing today. We welcome the interest and support of this highly engaged investment community and look forward to a mutually advantageous journey together. We are excited to continue building our consumer brand and in advancing a number of ambitious agendas including our proposed Life Sciences program to develop and fast track new and innovative formulations that we believe will positively impact a potential base of health and wellness afflicted individuals around the globe. To achieve these goals, we sincerely value our expanding relationship with an increasingly global investment community and look forward to working together as we build value for our shareholders by rapidly growing our exciting enterprise.”In related news, the Company advises it has hired Media Relations Publishing for the fee of €350,000 for marketing and communications services.As part of the Company’s disclosure obligations as a public issuer, ongoing financial and material filings can be found on the System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com.ON BEHALF OF THE BOARD,-Doug Chloupek-Doug Chloupek, CEO & Founder Juva Life Inc. email@example.comAbout Juva Life Inc. (CSE: JUVA) (OTC: JUVAF) (FRA: 4VV) Juva Life is working to bring the cannabis market face to face with the sector’s next generation investment grade business model. From in-house research, cultivation, manufacturing, retail, and delivery services, Juva employs state of the art tools in discovery, development, and data science to identify new molecular profiles for major unmet medical needs. Our initial focus is on cannabis, where we are deploying our platform to target consumer and pharma applications. Find out more at: https://juvalife.com/. For further information, please contact: Juva Life Investor Relations Tel: +1 833-333-5882 (JUVA) Email: firstname.lastname@example.orgForward Looking Statement This news release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as “may”, “would”, “could”, “will”, “likely”, “except”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook”, or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the objectives and business plans of the Company; ability to realize benefits from its recent corporate appointments; ability to retain its key personnel; the intention to grow the Company’s business and operations; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.Forward-looking information is based on the assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; and the Company’s ability to secure financing on reasonable terms.Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all, as well as all of the other risks as described in the Company’s management discussion and analysis for year ended December 31, 2019 under the heading “Risks and Uncertainties”. Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.The CSE does not accept responsibility for the adequacy or accuracy of this release.
Declaring "America is back," President-elect Joe Biden introduced his national security team, his first substantive offering of how he'll shift from Trump-era “America First” policies by relying on experts from the Democratic establishment to be some of his most important advisers. “Together, these public servants will restore America globally, its global leadership and its moral leadership,” Biden said Tuesday from a theater in his longtime home of Wilmington, Delaware. “It's a team that reflects the fact that America is back, ready to lead the world, not retreat from it.”
Biotox Gold reviews analyses its ingredients, benefits and dosage. Weight loss supplement facts and proofs revealed! Find out why Biotox Gold is great for burning that extra fat! Biotox Gold Biotox Gold reviews analyses its ingredients, benefits and dosage. Weight loss supplement facts and proofs revealed! Find out why Biotox Gold is great for burning that extra fat!New York, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Is Biotox Gold an all-natural solution for weight solution? Here’s one of the comprehensive Biotox Gold reviews that answer all the uncertainties regarding the supplement. If you’ve ever tried to lose weight, you’d know what a hassle it is.The excess fat on the body, looks like that hot melting cheese from a cheese-burst pizza, just uglier! Obesity has become a widespread lifestyle ailment, that is plaguing a majority of the population. Today, you have 20-year-olds, who cannot run up a flight of stairs.Biotox Gold Review - Weight Loss Formula Any Good? Unfortunately, as rampant as the disease is, exactly that vast, is the market for products that claim to combat obesity and help weight loss. There are tons of fat burners that work on various principles and make tall claims about helping you torch fat, and become a healthier version of yourself.>>> Must See: Critical Report on Biotox Gold Released: This May Change Your Mind!However, a lot of fat burners depend on artificial methods to burn fat, and more often than not, work on a laxative principle, something that you’d find incredibly uncomfortable to deal with, on a daily basis.Here’s where Biotox Gold comes in. The manufacturer claims that this can help you in your battle against obesity by targeting the root of the problem. Can it? Well, let’s find out in this Biotox Gold review.Product Name Biotox Gold Main Benefits Helps in reducing the fat storage in your body Category Weight Loss Ingredients Malabar Tamarind, Panax Ginseng, Guarana, Grape Seed Extract, Capsicum Eleuthero Root Irvingia Gabonensis, Maca Root, Glycyrrhizin, African Mango Extract, Raspberry ketone L-Carnitine, Tryptophan, Chromium, Green Tea Extract Administration Route Oral Dosage Consume 10 drops, 3 times a day Price $79.00 (Check for Discount) Availability Only through the official website What is Biotox Gold? The Biotox Gold supplement liquid weight loss formula is a natural concoction that aims to fix the health problems that arise due to the presence of uncontrolled belly fat.This liquid supplement is made up of totally natural ingredients and helps users experience more energy, optimum immunity, and a better, more efficient metabolism, by addressing the main problem of obesity - overeating.It helps you feel full, and aids in controlling your appetite and those terrible hunger pangs. Biotox Gold is known for helping the body burn stubborn belly fat and detoxifying the internal pathways of our body, ridding it of harmful toxins and metabolic waste.What is the formula behind Biotox Gold? The formula for Biotox Gold is a proprietary blend of several natural ingredients. Based on Biotox Gold reviews, the supplement could help you target the ‘endocrine-disrupting chemicals’, that are known to disrupt energy levels.If you increase energy levels, you can work out more, and lose more weight, and improve your quality of life overall, by being less lethargic. Biotox Gold not only targets fat stored in your body but also acts as a sort of holistic tonic, improving your overall health.Biotox Gold ingredientsThe ingredients in Biotox Gold are completely natural and can be found commonly around the world. It isn’t the individual ingredients that make Biotox Gold special. It is the magic of these ingredients together, that makes this supplement an effective aid in your fat-burning quest.The Biotox Gold ingredients are; * Malabar Tamarind * Panax Ginseng * Guarana * Grape Seed Extract * Capsicum Eleuthero Root * Irvingia Gabonensis * Maca Root * Glycyrrhizin * African Mango Extract. * Raspberry ketone * L-Carnitine * Tryptophan * Chromium * Green Tea ExtractMalabar TamarindKnown colloquially in India as ‘kudam puli’, this is a tropical fruit gaining considerable attention for its weight loss benefits. The fruit looks like a small pumpkin with colors varying from green to yellow.Known well throughout Southeast Asia, coastal Karnataka, and Kerala, the fruit is quite commonly used in supplements and sold commercially. Apart from that, it has its culinary uses as well.The fruit first shot to fame in 2012, when American celebrity doctor Dr. Oz promoted the extract of the fruit as a great weight-loss aid. The fruit also supposedly provides energy, detoxifies the body, and promotes cardiovascular and digestive health.Panax GinsengPopularly used in traditional Chinese medicine to stimulate fat loss, delay fat absorption, and modify fat formation, this ingredient is capable of promoting higher energy levels in the body as well.There are also some other studies that suggest that consuming Panax ginseng may improve immunity and other bodily functions.GuaranaThis popular ingredient also forms the basis of many health supplements worldwide. Primarily, its caffeine content might help you lose weight by boosting your metabolism.Furthermore, guarana may suppress genes that aid in producing fat cells and could help promote genes that slow down the deposit of fat in the body. And finally, guarana may also help by delaying the aging process.Grape Seed ExtractFull of antioxidants, this extract could improve heart health, boost overall health and wellness, and more.Capsicum Eleuthero RootThe tasty capsicum has been found to aid in weight loss as it naturally accelerates the fat-burning process, and also helps the body to maintain a high rate of metabolism.Irvingia GabonensisA tree, native to West Africa it bears a fruit that is similar in dimensions to a mango. The seeds of this fruit are used to make medicines, and researchers have been working with this ingredient for combating problems like weight gain, high cholesterol and diabetes.Maca RootOccurring high up in the mountains in Peru, Maca Root is notoriously difficult to procure. Touted as highly nutritious, it increases the libido in both men and women, and could also help relieve the symptoms of menopause, and improve your mood. It is a great energy enhancer and a performance booster for those into sports.GlycyrrhizinThis strange-sounding ingredient occurs mainly in licorice root and has been used in traditional medicine for centuries to alleviate the symptoms of bronchitis, gastritis, and jaundice. It helps in weight loss by aiding with digestion and metabolism to ensure our system runs smoothly.Raspberry ketoneThis compound happens to be the chemical form of raspberries and could help with battling obesity. There has been some research conducted on animals, or in test tubes, that shows that raspberry ketones might help in increasing metabolism, the rate of the body’s fat-burning capabilities, and the reduction of our appetites.African Mango Extract.This ingredient is a great source of fiber and can help promote weight loss while reducing blood cholesterol and maintaining blood sugar levels.L-CarnitineThis compound plays a vital role in helping our body burn fat, and also prevents that fat from returning and depositing itself on our body. This is a great supplement to include in your regime when you’re trying to lose weight and burn calories.TryptophanThis compound works as an appetite suppressor, and prevents us from binge eating, and also increases the feeling of being full after a meal, to prevent extra helpings from going down.ChromiumIn the recommended dosage, chromium can help lower your appetite, help you burn more calories, help you burn fat, and boost muscle mass.Green Tea ExtractGreen tea is known to be an excellent antioxidant. It helps the body flush out toxins through the bladder, and can help in your weight loss journey by acting as an excellent diuretic.Taking Biotox Gold can negate the necessity of having 10 cups of green tea every day, as it provides you with a good dose of green tea extract in each drop.When these ingredients come together, they create a proprietary formula, that can help you burn fat, regulate your metabolism and also maintain good blood pressure and blood sugar levels, becoming a great companion in your fat burning journey.>>> Already decided to try? Click here to order Biotox Gold from the official websiteWhat benefits can you expect from this? There are many benefits to using a natural weight loss supplement:- * Biotox Gold reviews reveals that It is a totally natural supplement, that doesn’t rely on any artificial ingredients to help you lose weight. It doesn’t act as a laxative and doesn’t release harmful chemicals that could cause side effects. * Not only does Biotox Gold help burn fat, but it also helps to improve your energy levels. Energy levels can have a major influence in your daily life. Higher energy levels may help people feel more motivated to exercise even more frequently, and can even alleviate moods. * Biotox Gold also helps optimize hormonal health, and by doing so, it aids in metabolism regeneration and body weight management. Every day can feel fresher than the last when you’re taking this supplement. * There’s a 60-day money-back guarantee if you aren’t satisfied with the drops. So don’t worry about your investment going to waste, if Biotox Gold does not work for you.What is the recommended dosage, how do you use it, and what are the side effects? Unlike many of the weight loss supplements in the market, Biotox Gold does not come in capsule form. It is a liquid-based formula, and it can be taken as a liquid tincture.You need to take anywhere between 1 to 6 drops of Biotox Gold under your tongue. Popularly described as the ‘30 second morning ritual’, this supplement should be taken at the beginning of the day so it works immediately.The liquid form means that it gets absorbed faster than traditional capsules and softgels.When it comes to side effects, with Biotox Gold, you need not worry too much. Biotox Gold supplement consists chiefly of natural ingredients, so there are no nasty side effects, common in allopathic medicines.With Biotox Gold, you can be rest assured of losing weight naturally, without falling prey to side effects.Is this a magic solution for weight loss? No, unfortunately, Biotox Gold is not a magic weight loss formula that will start working as soon as you take the first drop. It is a natural supplement with natural ingredients that you need to give at least 2 to 3 months to work effectively on your system.As per Biotox Gold Supplement review, the supplement does claim to help you lose weight, but it does so in a healthy manner, without the laxative effect that most supplements are known for.People who expect overnight results may be disappointed with Biotox Gold, but if you’re one of those that understand how natural supplements work, this product could help you.How long does it take to see results? Normally, with OTC weight loss pills, results can be apparent within a couple of weeks, but with Biotox Gold, you need to wait a couple of months for some results.This is because Biotox Gold supplement is totally natural, and doesn’t rely on chemicals to help you lose weight. The flip side of a natural supplement is that it takes time to show results. So, if you’re patient and you use the supplement regularly, you may see results within 90 days.How long do the results stay? The results of Biotox Gold may take time to be apparent, but they will stay for at least 1 to 2 years.As stated by Biotox Gold reviews, Biotox Gold supplement has a long-term benefit on the human body, and does not fail to show results provided you stick to the recommended dosage, and follow all other instructions accordingly.What does it cost, and where can you get it? Biotox Gold is available in various packages. You can get either 1, 3, or 6 bottles, and each package contains free shipping. * 1 bottle costs $79 * 3 bottles cost $165 * 6 bottles cost $252It is prudent to buy the packs with either 3 or 6 bottles, because this is a supplement that you may need to use for a considerable period of time, before you see any results, on account of it being completely natural and devoid of fast-acting fat-burning chemicals.You can buy the product on the official website. The product isn’t available on other eCommerce websites, and that is good because then you’re assured of quality if you buy it straight from the official website.Biotox Gold Reviews- Final VerdictAs with any weight loss supplement, Biotox Gold was also riddled with questions. Would it work, what are the side effects, etc. Well, Biotox Gold is a welcome change for those who are frustrated with hitting dead ends in their weight loss journey after trying numerous fat burning pills, and running rounds outside the doctor’s office.Just as Biotox Gold review, this supplement is for those who wish to beat obesity naturally. This isn’t a fast-acting product that can help you achieve results overnight. Rather, it is a long-term solution to obesity, and can prevent the re-accumulation of fat in the human body.Moreover, for those who don’t want the stigma of eating pills, this supplement comes in a liquid form, and can easily be absorbed into the human body.>>> Click Here to Order Biotox Gold from the Official Website (60 Days Money-Back Guarantee) Media Contact / Support: Biotox Gold - email@example.com Disclosure by content creatorStatements on the Biotox Gold website have not been evaluated by the Food and Drug Administration. Products are not intended to diagnose, treat, cure or prevent any disease. If you are pregnant, nursing, taking medication, or have a medical condition, consult your physician before using the product.This press release is for informational purposes only. The information does not constitute advice or an offer to buy. Any purchase done from this story is done at your own risk. Consult a qualified professional before any such purchase. Any purchase done from these links is subject to the final terms and conditions of the website's selling. The content on this release does not take any responsibility directly or indirectly.KISS PR NEWS DISCLAIMERThis news has been published for the above source. If you purchase any items using the product and services mentioned in the link, read and accept the terms at your own risk. — Content creator did not involve the KISS PR news desk in the creation or image in this content. — KISS PR, and its distribution partners are not directly or indirectly responsible for any claims made in the above statements. — Contact the vendor of the product directly. — KISS PR or its distribution partners are not responsible for news ranking or SEO of news and its rankings. Ultimately it is always a final decision of distribution partners, and how it indexes on search engines and distribution sites. — KISS PR, or its distribution partners have no control / cannot change any ranks factors. Further reproduction or distribution beyond the intended recipient is prohibited without the Owner’s prior written consent. Including this disclosure. Story.KissPR.com This news has been published for the above source. Biotox Gold [ID=15297]The content publisher provides the information without warranty off any kind. We do not accept any responsibility or liability for the legal facts, content accuracy, photos, videos. Always consult a licensed professional for legal and medical advice. If you have any complaints or copyright issues related to this article, kindly contact the source of the story above.Attachment * Biotox Gold
With police brutality continuing to devastate Black families and the coronavirus ravishing Black America disproportionately, the world was driven to the significance of this year's Juneteenth more than ever before. Months later, the song — and others focused on protesting, police brutality and the overall Black experience — are taking center stage at the 2021 Grammy Awards. “There could have been a different approach as far as releasing the record and capitalizing off of timings of other things, but we really wanted to get it out during a time where we could all remember the feeling and the energy,” Derek Dixie, a longtime collaborator of Beyoncé's who co-wrote the song with the pop star, said in an interview with The Associated Press.
(Bloomberg) -- Technology stocks can notch further gains even as investors move beyond pandemic trades, according to Principal Global Investors.Cheap borrowing costs and the growing importance of intangible assets mean that some tech firms can surge even amid a market rotation toward value and cyclical names, said Alan Wang, a portfolio manager at the global equities arm. The past year is proving to be a lesson in valuing technology companies the right way, he said.“Never underestimate the impact of technology,” Wang, who helps manage about $507 billion of assets in Hong Kong, said in an interview. “We see a huge re-rating of new technology companies no matter if they are making electric cars, ventilators or vaccines.”This year’s hottest trading strategy -- piling into technology stocks benefiting from stay-at-home trends -- finally took a breather this month as Covid-19 vaccine candidates showed promise. Beaten-down shares tied to activity in pandemic-battered economies became the leaders. However, Wang cautioned that investors may be discounting the ability of innovation-linked firms to navigate any downturn in sentiment, particularly in a low interest-rate environment.Star Managers With Lots to Lose Are Unmoved by Tech RoutAt the same time, some of Wall Street’s biggest names are shaking up their investment models to evaluate if intangibles such as brands and patents can be treated as assets rather than expenses to gauge the value of a stock. “It’s a totally new valuation system. I can see a lot of investors getting their hands burnt by shorting high P/E multiple stocks,” Wang said.Principal Global likes companies in the renewable energy sector, as well as data centers and tower companies. The company also prefers the tech-heavy Chinese and Korean stock markets in its multi-asset portfolios, while also building positions in Japanese and small-cap stocks.And as the market snaps up everything cyclical, investors need to distinguish “value” companies backed by structural drivers from those rising purely on expectations of a vaccine, added portfolio manager Binay Chandgothia. Earnings at some energy and financial firms, for instance, are structurally challenged, he said.“Get back into value when you believe the assets can generate enough earnings -- otherwise go back into the safety of technology assets that are benefiting from the way we live,” he said.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
A New Zealand soldier has been charged with spying and will face up to 14 years in prison if found guilty. It is the first time somebody from the military has faced such a charge in New Zealand, at least in modern times, the New Zealand Defense Force said Wednesday. The soldier faces a total of 17 charges and will be tried in a court martial.
President-elect Joe Biden has prized staying power over star power when making his first wave of Cabinet picks and choices for White House staff, with a premium placed on government experience and proficiency as he looks to rebuild a depleted and demoralized federal bureaucracy. With an eye in part toward making selections who may have to seek approval from a Republican-controlled Senate, Biden has prioritized choosing qualified professionals while eschewing flashy names. In sharp contrast to President Donald Trump, who openly distrusted the very government he led, Biden has showcased a faith in bureaucracy that was born out of his nearly five decades in Washington.